Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results symbols : BLUE save search
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -12.87%
H: 2.11%
C: 1.27%
results
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
Published: 2023-11-07 (Crawled : 16:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 4.24%
H: 3.2%
C: 2.91%
financial results
bluebird bio to Host Third Quarter 2023 Financial Results Conference Call
Published: 2023-10-24 (Crawled : 14:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.39%
H: 7.19%
C: 2.74%
conference financial results
bluebird bio Reports Second Quarter 2023 Financial Results and Highlights Operational Progress
Published: 2023-08-08 (Crawled : 13:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -1.94%
H: 24.08%
C: 10.2%
financial results
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-07 (Crawled : 23:00) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: -0.16%
H: 0.0%
C: -0.33%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.03%
H: 0.41%
C: -0.07%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -6.89%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -7.93%
financial results
bluebird bio to Host Second Quarter 2023 Financial Results Conference Call and Provide Commercial Update
Published: 2023-07-25 (Crawled : 13:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.0%
H: 6.77%
C: -1.82%
conference update commercial financial results
Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-08 (Crawled : 20:00) - prnewswire.com
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: -0.53%
H: 2.31%
C: 0.8%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.6%
H: 0.54%
C: 0.0%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: -2.76%
H: 5.17%
C: 2.29%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -3.22%
H: 22.09%
C: 16.39%
financial results
bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational Progress
Published: 2023-03-29 (Crawled : 12:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -14.81%
H: 1.63%
C: -11.41%
year financial results
Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Published: 2023-03-06 (Crawled : 01:00) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: 0.43%
H: 1.03%
C: -4.82%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.1%
H: 0.42%
C: -0.68%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: -0.37%
H: 1.79%
C: -1.62%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.96%
H: 0.96%
C: -5.59%
year financial results
bluebird bio Reports Third Quarter 2022 Financial Results and Highlights Operational Progress
Published: 2022-11-07 (Crawled : 13:20) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.14%
H: 11.61%
C: 9.84%
financial results
bluebird bio Reports Fourth Quarter and Full Year 2021 Financial Results, Highlights Operational Progress and Provides Corporate Update
Published: 2022-03-04 (Crawled : 23:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
financial results blue report results
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
Published: 2021-12-01 (Crawled : 12:30) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: -0.65%
H: 10.47%
C: 1.26%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.39%
H: 5.38%
C: -1.66%
financial results results
bluebird bio Reports Third Quarter Financial Results and Recent Operational Progress
Published: 2021-11-05 (Crawled : 12:00) - biospace.com/
FRT | $98.53 1.54% 0.0% 450K
|
Finance
|
| O: 1.56%
H: 3.77%
C: 1.48%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -29.61%
H: 0.0%
C: 0.0%
financial results results
bluebird bio Reports Second Quarter Financial Results and Provides Operational Update
Published: 2021-08-09 (Crawled : 12:15) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -25.23%
H: 1.03%
C: -6.3%
financial results results
TCR² Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-05 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 0.08%
H: 7.43%
C: 7.36%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -0.92%
H: 5.25%
C: 4.44%
financial results results
Bristol Myers Squibb Reports Second Quarter Financial Results for 2021
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.16%
H: 2.06%
C: 1.67%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.2%
H: 2.36%
C: -0.88%
AGEN | $4.97 -7.96% -8.65% 1.7M
|
Health Technology
|
| O: 1.0%
H: 5.17%
C: 4.57%
financial results results
Bristol Myers Squibb Reports First Quarter Financial Results for 2021
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -1.56%
H: 0.4%
C: -3.25%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: 0.12%
H: 0.4%
C: -0.36%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.2%
H: 0.66%
C: -0.72%
financial results results
The New England Journal of Medicine Publishes Results from Pivotal Phase 2 KarMMa Study of Idecabtagene Vicleucel (Ide-cel, bb2121), an Investigational BCMA-Directed CAR T Cell Therapy
Published: 2021-02-24 (Crawled : 00:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.3%
H: 3.32%
C: 2.78%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 2.65%
H: 1.48%
C: -1.44%
phase 2 therapy results t-cell car-t cel
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.